Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mephentermine vs Phenylephrine for Hemodynamic Stability in C-Section
NCT05706727Phase 3Completed
- Sponsor
- KIST Medical College and Teaching Hospital
- Start
- Mar 2023
- Primary completion
- Apr 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mephentermine in hypotension (2 arms), sponsored by KIST Medical College and Teaching Hospital. Primary endpoint: Hemodynamic Stability at 6 months. Started Mar 2023; status: completed.
02
Drugs
mephentermine
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT05706727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05706727.